Search research articles
Contact Us
Filters
Showing results (1-10 of 50) with videos related to
Page
of 5
Sort By:
Annals of the New York Academy of Sciences
|
April 5, 2013
Challenges in the clinical development of PI3K inhibitors
Cristian Massacesi, Emmanuelle di Tomaso, Nathalie Fretault, et al.
Haematologica
|
October 20, 2018
Antitumor synergy with SY-1425, a selective RARα agonist, and hypomethylating agents in retinoic acid receptor pathway activated models of acute myeloid leukemia
Michael R McKeown, Liv Johannessen, Emily Lee, et al.
Nature
|
March 22, 2002
Tumour biology: herceptin acts as an anti-angiogenic cocktail
Yotaro Izumi, Lei Xu, Emmanuelle di Tomaso, et al.
Expert Opinion on Investigational Drugs
|
November 29, 2007
Antiangiogenic agents for the treatment of glioblastoma
Elizabeth R Gerstner, Dan G Duda, Emmanuelle di Tomaso, et al.
IEEE Transactions on Medical Imaging
|
February 20, 2007
Robust 3-D modeling of vasculature imagery using superellipsoids
James Alexander Tyrrell, Emmanuelle di Tomaso, Daniel Fuja, et al.
Nature
|
February 20, 2004
Pathology: cancer cells compress intratumour vessels
Timothy P Padera, Brian R Stoll, Jessica B Tooredman, et al.
Nature Reviews. Neuroscience
|
July 24, 2007
Angiogenesis in brain tumours
Rakesh K Jain, Emmanuelle di Tomaso, Dan G Duda, et al.
Plos One
|
April 9, 2009
PDGF-C induces maturation of blood vessels in a model of glioblastoma and attenuates the response to anti-VEGF treatment
Emmanuelle di Tomaso, Nyall London, Daniel Fuja, et al.
Seminars in Oncology
|
December 6, 2006
Combined vascular endothelial growth factor-targeted therapy and radiotherapy for rectal cancer: theory and clinical practice
Christopher G Willett, Sergey V Kozin, Dan G Duda, et al.
Neoplasia (New York, N.Y.)
|
March 21, 2012
Merlin/NF2 regulates angiogenesis in schwannomas through a Rac1/semaphorin 3F-dependent mechanism
Hon-Kit Wong, Akio Shimizu, Nathaniel D Kirkpatrick, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 50) with videos related to
Sort By:
Page
of 5
Annals of the New York Academy of Sciences
|
April 5, 2013
Challenges in the clinical development of PI3K inhibitors
Cristian Massacesi, Emmanuelle di Tomaso, Nathalie Fretault, et al.
Haematologica
|
October 20, 2018
Antitumor synergy with SY-1425, a selective RARα agonist, and hypomethylating agents in retinoic acid receptor pathway activated models of acute myeloid leukemia
Michael R McKeown, Liv Johannessen, Emily Lee, et al.
Nature
|
March 22, 2002
Tumour biology: herceptin acts as an anti-angiogenic cocktail
Yotaro Izumi, Lei Xu, Emmanuelle di Tomaso, et al.
Expert Opinion on Investigational Drugs
|
November 29, 2007
Antiangiogenic agents for the treatment of glioblastoma
Elizabeth R Gerstner, Dan G Duda, Emmanuelle di Tomaso, et al.
IEEE Transactions on Medical Imaging
|
February 20, 2007
Robust 3-D modeling of vasculature imagery using superellipsoids
James Alexander Tyrrell, Emmanuelle di Tomaso, Daniel Fuja, et al.
Nature
|
February 20, 2004
Pathology: cancer cells compress intratumour vessels
Timothy P Padera, Brian R Stoll, Jessica B Tooredman, et al.
Nature Reviews. Neuroscience
|
July 24, 2007
Angiogenesis in brain tumours
Rakesh K Jain, Emmanuelle di Tomaso, Dan G Duda, et al.
Plos One
|
April 9, 2009
PDGF-C induces maturation of blood vessels in a model of glioblastoma and attenuates the response to anti-VEGF treatment
Emmanuelle di Tomaso, Nyall London, Daniel Fuja, et al.
Seminars in Oncology
|
December 6, 2006
Combined vascular endothelial growth factor-targeted therapy and radiotherapy for rectal cancer: theory and clinical practice
Christopher G Willett, Sergey V Kozin, Dan G Duda, et al.
Neoplasia (New York, N.Y.)
|
March 21, 2012
Merlin/NF2 regulates angiogenesis in schwannomas through a Rac1/semaphorin 3F-dependent mechanism
Hon-Kit Wong, Akio Shimizu, Nathaniel D Kirkpatrick, et al.
Page
of 5